- Nachrichtendetail
-
17.06.2024 08:02:43 - dpa-AFX: *ASTRAZENECA : FDA OKS IMFINZI PLUS CHEMOTHERAPY FOR MISMATCH REPAIR DEFICIENT ADVANCED OR RECURRENT ENDOMETRIAL CANCER
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
ASTRAZENECA PLC DL-,25 | 886455 | Xetra | 147,350 | 27.06.24 13:59:55 | -1,100 | -0,74% | 147,400 | 147,600 | 148,200 | 148,450 |
